Pharmaceutical speciality concerned with serving the pharmaceutical needs of the population through the selection, preparation, procurement, purchasing, control, dispensing, information of medicines and other activities aimed at achieving appropriate, safe and cost-effective use of medicines and medical devices, for the benefit of patients in hospital and outpatient care, as well as for the ... Read more
It is a private health establishment of public interest, expressly defined by state and regional laws, from which the community pharmacist ensures the population's access to medicines and health products, helping patients in the correct process of safe, effective, efficient and responsible use, getting involved in achieving results in the health care system, and in the ... Read more
Clinical study other than a clinical trial.
Clinical research that generates high quality knowledge to develop therapeutic tools that contribute to the prevention, alleviation and cure of diseases and to the improvement of the quality of life of the population.
Documentation on a product that the company submits to the DGCSF in order to initiate the negotiation of financing by SNS.
It is the first step in the development of any orphan medicinal product but involves approval of the use of the medicinal product for the designated condition. This designation is granted by the Committee for Orphan Medicinal Products and Medicinal Products (COMP) of the European Medicines Agency (EMA).
A public law corporation that represents, coordinates and cooperates with the Pharmaceutical Profession, both at national and international level.
A code or registration number that identifies each presentation of a medicinal product. It is an element of unequivocal identification and traceability. The code consists of seven digits and is displayed on the two main faces of the outer packaging.
Authorisation to market a medicinal product. In Spain, the body that grants authorisation to market a medicinal product is the AEMPS.
